Search

Your search keyword '"Golay J."' showing total 268 results

Search Constraints

Start Over You searched for: Author "Golay J." Remove constraint Author: "Golay J." Search Limiters Full Text Remove constraint Search Limiters: Full Text
268 results on '"Golay J."'

Search Results

1. The Multipoint Morisita Index for the Analysis of Spatial Patterns

2. Potency assays and biomarkers for cell-based advanced therapy medicinal products

4. Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use

5. Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry

6. Identification of Human SARS-CoV-2 Monoclonal Antibodies from Convalescent Patients Using EBV Immortalization

7. A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies

8. Mesenchymal Stem/Stromal Cells: A NOVEL, MULTI-SITE GMP PROTOCOL TO MANUFACTURE PROSPECTIVELY-ISOLATED, ALLOGENEIC BONE MARROW MSCS FOR A PHASE 1B CLINICAL TRIAL IN PROGRESSIVE DIABETIC KIDNEY DISEASE

9. Mesenchymal Stem/Stromal Cells: INTERIM REPORT FROM THE NEPHSTROM MULTI-CENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE-1B CLINICAL TRIAL OF A NOVEL MESENCHYMAL STROMAL CELL THERAPY IN PROGRESSIVE DIABETIC KIDNEY DISEASE

13. Third-party bone marrow-derived mesenchymal stromal cell infusion before liver transplantation: A randomized controlled trial

17. Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B cells opsonized with anti-CD20 antibodies

18. 117 - Mesenchymal Stem/Stromal Cells: INTERIM REPORT FROM THE NEPHSTROM MULTI-CENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE-1B CLINICAL TRIAL OF A NOVEL MESENCHYMAL STROMAL CELL THERAPY IN PROGRESSIVE DIABETIC KIDNEY DISEASE

19. 118 - Mesenchymal Stem/Stromal Cells: A NOVEL, MULTI-SITE GMP PROTOCOL TO MANUFACTURE PROSPECTIVELY-ISOLATED, ALLOGENEIC BONE MARROW MSCS FOR A PHASE 1B CLINICAL TRIAL IN PROGRESSIVE DIABETIC KIDNEY DISEASE

21. A glitch in the Natrix: cryptic presence of alien grass snakes in Switzerland

22. Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation

24. Rituximab induces different but overlapping sets of genes in human B-lymphoma cell lines

25. Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis

27. T CELL ORIGIN OF CYTOKINE INDUCED KILLER CELLS

28. A human immunodeficiency virus type 1 pol gene-derived sequence (cPPT/CTS) increases the efficiency of transduction of human nondividing monocytes and T lymphocytes by lentiviral vectors

29. Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories

30. Lentiviral vectors show dramatically increased efficiency of transduction of human leukemic cell lines

31. The polo-like kinase 1 (PLK1) inhibitor NMS-P937 is \ud effective in a new model of disseminated primary CD56+ acute monoblastic leukaemia

32. Time Fluctuation Analysis of Forest Fire Sequences

33. The Multipoint Morisita Index for the Analysis of Geodemographic Data

34. Tie2 Expressing Monocytes in the Spleen of Patients with Primary Myelofibrosis

35. Multifractal Portrayal of the Distribution of the Swiss Population

36. Multipoint-Morisita Index for the Analysis of Spatial Patterns

37. Multifractal Analysis of Forest Fires in Complex Regions

38. Spatial Point Pattern Analysis of Environmental Data using R

40. The in vivo mechanism of action of CD20 monoclonal antibodies depends on local tumor burden

41. High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis

43. Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients

48. The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemia

49. Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients

Catalog

Books, media, physical & digital resources